Company Active LTD

Company profile

Okulo Ltd

Home (UK) | United Kingdom

Okulo Ltd is a UK company with status active founded in 2018 based in South West England.

CRN
11251527
Founded
2018
Age
8

Overview

Legal name
OKULO LTD
Region
South West England
Registered address
C/O SQUAREWORKS, 17-19
BERKELEY SQUARE
BRISTOL
ENGLAND
BS8 1HB
Insolvency history
No

Corporate ownership

Updated 06 Jun 2026 16:52

Okulo Ltd
No active corporate controller recorded.

Company events

Reference milestones and recent Companies House filing stream events.

6 events
30 Sep
2026

Accounts due

Accounts Due

Next accounts due date

26 Mar
2026

Confirmation statement due

Confirmation Due

Next confirmation statement due date

12 Mar
2025

Confirmation statement filed

Confirmation

Last confirmation statement made up date

31 Dec
2024

Accounts filed

Accounts

Last accounts made up date

05 Nov
2024

Termination Director Company With Name Termination Date

Officers

TM01 | Transaction MzQ0MjAzMjU2MGFkaXF6a2N4

Published 05 Nov 2024 11:35

13 Mar
2018

Incorporated

Inception

Company registered at Companies House

Public funding

7 awards
First funded
2020
Funded years
2020, 2022, 2023
Age at first award
2 years

Projects

2023 Innovation Loans Lead participant

Accelerating digital eye care to market

20 Jun 2023 to 20 Jun 2024

Awarded
£850,000
Total cost £850,000

OKKO Health is an eye care digital health company, based in Bristol, and making medical-grade apps that eye specialists can prescribe so that people who live with long-term eye disease can safely monitor their vision between in-person appointments. The current product is for macular degeneration and diabetic eye disease, which are both leading causes of a...

2022 Collaborative R&D Lead participant

Patient-centred smartphone AI for protecting vision in macular disease

1 Aug 2022 to 31 Jan 2025

Awarded
£793,450
Total cost £1,133,500

OKKO Health is a software medical device company developing companion apps for people with chronic eye disease. The app consists of short games which use vision science technology to measure visual function through the data produced. This project is to develop an AI product to identify the very early visual symptoms indicative of either development or wor...

2020 Collaborative R&D Lead participant

Harnessing mobile devices to create a sustainable way of delivering eye care at scale, through COVID and beyond

1 Nov 2020 to 31 Jul 2021

Awarded
£138,318
Total cost £172,897

Okulo Ltd (trading as OKKO Health) develop smartphone software for home-monitoring of vision. This project is to drive the development of a technological system and corresponding patient pathway to allow AI-driven home-monitoring of vision for patients who would otherwise have had to come for in-person hospital eye clinic appointments. This project will d...

2020 Small Business Research Initiative Lead participant

Integration of home-monitoring of macular disease in NHS

1 Oct 2020 to 31 Dec 2020

Awarded
£59,338
Total cost £59,338

This project is to drive the development of a technological system and corresponding patient pathway to allow AI-driven home-monitoring of vision for patients who would otherwise have had to come for in-person hospital eye clinic appointments, specifically for those living with macular disease. This project will develop diagnostic biomarkers from app data...

2020 Feasibility Studies Lead participant

Leveraging home-monitoring vision tech for urgent tele-ophthalmology appointments during COVID and beyond

1 Jul 2020 to 30 Sep 2020

Awarded
£25,400
Total cost £25,400

Due to COVID-19, all routine face-to-face eye care appointments have been suspended (both in hospital ophthalmology and in community opticians). Since routine appointments comprise approximately 80% of all eye care appointments, and in 2019 eye units became the busiest hospital outpatient speciality, this is a major disruption for the NHS as a whole, and ...

2020 Feasibility Studies Lead participant

Continuity grant for “Data-driven eye care” project 46054

1 Jun 2020 to 30 Nov 2020

Awarded
£75,000
Total cost £75,000

no public description

2020 Collaborative R&D Lead participant

Data-driven eye care

1 Apr 2020 to 31 Dec 2020

Awarded
£149,714
Total cost £299,428

The measurement of sight is the front door to eye care, but currently this relies upon a professional. As such, remote-monitoring of eye disease is not currently possible. The lack of patients' ability to self-monitor on a regular basis can result in a delay in identifying a deterioration in sight. Late treatment makes eye disease much more difficult to t...

Product types

Collaborative R&D Feasibility Studies Innovation Loans Small Business Research Initiative